Drais Pharmaceuticals, Inc.

IN VITRO DIAGNOSTICS Agendia BV Agendia raises $65mm through late-stage round A year after withdrawing its IPO filing, molecular diagnostics firm Agendia BV has raised $65mm in what appears to

It’s the 10th anniversary of START-UP ’s A-List. Since we began counting and sorting Series A rounds, then highlighting the most intriguing ones, we’ve never seen a year quite like 2013. On the publi

Astellas is signaling its strategic intention to move more deeply into vaccines through a risk-sharing and licensing alliance with two firms for a product against respiratory syncytial virus (RSV). Th

Forma Therapeutics Holdings LLC has begun reaching out to academics and other research groups to create programs it can use for its own pipeline or to feed its alliances with larger drug firms. In o